Literature DB >> 8504747

Aldosterone stimulated differentiation of mouse 3T3-L1 cells into adipocytes.

C M Rondinone1, D Rodbard, M E Baker.   

Abstract

We find that 1-10 nM aldosterone can induce differentiation of 3T3-L1 cells into adipose cells as evaluated by microscopic accumulation of fat droplets and quantitative measurement of triglycerides and of glycerol-3-phosphate dehydrogenase, an enzyme specific for adipocyte differentiation. Moreover, the aldosterone antagonist ZK91587 inhibits aldosterone-but not glucocorticoid-mediated differentiation of 3T3-L1 cells. Steroid binding assays with 3T3-L1 cells indicate the presence of specific binding sites for aldosterone. We conclude that there is an aldosterone receptor-mediated pathway for terminal differentiation of 3T3-L1 cells into adipose cells. Receptors for aldosterone have also been found in a variety of cells that do not function to regulate sodium and potassium transport. The aldosterone receptor may have a role in regulation expression of genes involved in differentiation of these cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8504747     DOI: 10.1210/endo.132.6.8504747

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  25 in total

Review 1.  Aldosterone: role in the cardiometabolic syndrome and resistant hypertension.

Authors:  Adam Whaley-Connell; Megan S Johnson; James R Sowers
Journal:  Prog Cardiovasc Dis       Date:  2010 Mar-Apr       Impact factor: 8.194

2.  Insulin signaling in adipose tissue of patients with primary aldosteronism.

Authors:  R Urbanet; C Pilon; F Giorgino; R Vettor; F Fallo
Journal:  J Endocrinol Invest       Date:  2011-02       Impact factor: 4.256

Review 3.  Obesity, sleep apnea, aldosterone, and hypertension.

Authors:  Theodore L Goodfriend
Journal:  Curr Hypertens Rep       Date:  2008-06       Impact factor: 5.369

4.  Dietary fructose-related adiposity and glucocorticoid receptor function in visceral adipose tissue of female rats.

Authors:  Sanja Kovačević; Jelena Nestorov; Gordana Matić; Ivana Elaković
Journal:  Eur J Nutr       Date:  2014-01-14       Impact factor: 5.614

5.  Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines.

Authors:  Christine Guo; Vincent Ricchiuti; Bill Q Lian; Tham M Yao; Patricia Coutinho; José R Romero; Jianmin Li; Gordon H Williams; Gail K Adler
Journal:  Circulation       Date:  2008-04-21       Impact factor: 29.690

Review 6.  The metabolic syndrome in primary aldosteronism.

Authors:  Francesco Fallo; Giovanni Federspil; Franco Veglio; Paolo Mulatero
Journal:  Curr Diab Rep       Date:  2008-02       Impact factor: 4.810

7.  Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure.

Authors:  Flora Sam; Toni-Ann S Duhaney; Kaori Sato; Richard M Wilson; Koji Ohashi; Saki Sono-Romanelli; Akiko Higuchi; Deepa S De Silva; Fuzhong Qin; Kenneth Walsh; Noriyuki Ouchi
Journal:  Endocrinology       Date:  2009-10-22       Impact factor: 4.736

Review 8.  Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension.

Authors:  James R Sowers; Adam Whaley-Connell; Murray Epstein
Journal:  Ann Intern Med       Date:  2009-06-02       Impact factor: 25.391

9.  In vivo tissue specific modulation of rat insulin receptor gene expression in an experimental model of mineralocorticoid excess.

Authors:  J Campión; V Lahera; V Cachofeiro; B Maestro; N Dávila; M C Carranza; C Calle
Journal:  Mol Cell Biochem       Date:  1998-08       Impact factor: 3.396

Review 10.  Adipogenesis is under surveillance of Hsp90 and the high molecular weight Immunophilin FKBP51.

Authors:  Judith Toneatto; Nancy L Charó; Natalia M Galigniana; Graciela Piwien-Pilipuk
Journal:  Adipocyte       Date:  2015-05-13       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.